Metronidazole (Flagyl), misonidazole (Ro 07-0582), iron, zinc and sulphur compounds in cancer therapy

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

Organisationseinheiten

Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)16-19
Seitenumfang4
FachzeitschriftBritish Journal of Cancer
Jahrgang37
AusgabenummerSUPPL.3
PublikationsstatusVeröffentlicht - 1978

Abstract

The nitro radiosensitizers, metronidazole and misonidazole, have been shown to react rapidly with the sulphydryl compounds cysteine and cysteamine in the presence of ferrous ions. Similar reactions occur in the presence of copper ions but these are much slower. The initial interactions of the drugs and of oxygen with an iron-cysteine complex are extremely rapid: in the case of oxygen reaction half lives of 27 ms have been measured. Misonidazole also reacts rapidly with glutathione in the presence of ferrous ions and is subsequently reduced: metronidazole is reduced only slowly if at all. These reactions, which have been found to be inhibited by high concentrations of zinc ions, are discussed in the light of the known radiosensitizing and chemotherapeutic efficiencies of the nitro drugs and the side effect of peripheral neuropathy sometimes observed during their clinical use.

ASJC Scopus Sachgebiete

Ziele für nachhaltige Entwicklung

Zitieren

Metronidazole (Flagyl), misonidazole (Ro 07-0582), iron, zinc and sulphur compounds in cancer therapy. / Bahnemann, D.; Basaga, H.; Dunlop, J. R. et al.
in: British Journal of Cancer, Jahrgang 37, Nr. SUPPL.3, 1978, S. 16-19.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Bahnemann, D, Basaga, H, Dunlop, JR, Searle, AJ & Willson, RL 1978, 'Metronidazole (Flagyl), misonidazole (Ro 07-0582), iron, zinc and sulphur compounds in cancer therapy', British Journal of Cancer, Jg. 37, Nr. SUPPL.3, S. 16-19.
Download
@article{f09e5c460c3d4672a88bf6edbcc0337e,
title = "Metronidazole (Flagyl), misonidazole (Ro 07-0582), iron, zinc and sulphur compounds in cancer therapy",
abstract = "The nitro radiosensitizers, metronidazole and misonidazole, have been shown to react rapidly with the sulphydryl compounds cysteine and cysteamine in the presence of ferrous ions. Similar reactions occur in the presence of copper ions but these are much slower. The initial interactions of the drugs and of oxygen with an iron-cysteine complex are extremely rapid: in the case of oxygen reaction half lives of 27 ms have been measured. Misonidazole also reacts rapidly with glutathione in the presence of ferrous ions and is subsequently reduced: metronidazole is reduced only slowly if at all. These reactions, which have been found to be inhibited by high concentrations of zinc ions, are discussed in the light of the known radiosensitizing and chemotherapeutic efficiencies of the nitro drugs and the side effect of peripheral neuropathy sometimes observed during their clinical use.",
author = "D. Bahnemann and H. Basaga and Dunlop, {J. R.} and Searle, {A. J.} and Willson, {R. L.}",
note = "Copyright: Copyright 2012 Elsevier B.V., All rights reserved.",
year = "1978",
language = "English",
volume = "37",
pages = "16--19",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "SUPPL.3",

}

Download

TY - JOUR

T1 - Metronidazole (Flagyl), misonidazole (Ro 07-0582), iron, zinc and sulphur compounds in cancer therapy

AU - Bahnemann, D.

AU - Basaga, H.

AU - Dunlop, J. R.

AU - Searle, A. J.

AU - Willson, R. L.

N1 - Copyright: Copyright 2012 Elsevier B.V., All rights reserved.

PY - 1978

Y1 - 1978

N2 - The nitro radiosensitizers, metronidazole and misonidazole, have been shown to react rapidly with the sulphydryl compounds cysteine and cysteamine in the presence of ferrous ions. Similar reactions occur in the presence of copper ions but these are much slower. The initial interactions of the drugs and of oxygen with an iron-cysteine complex are extremely rapid: in the case of oxygen reaction half lives of 27 ms have been measured. Misonidazole also reacts rapidly with glutathione in the presence of ferrous ions and is subsequently reduced: metronidazole is reduced only slowly if at all. These reactions, which have been found to be inhibited by high concentrations of zinc ions, are discussed in the light of the known radiosensitizing and chemotherapeutic efficiencies of the nitro drugs and the side effect of peripheral neuropathy sometimes observed during their clinical use.

AB - The nitro radiosensitizers, metronidazole and misonidazole, have been shown to react rapidly with the sulphydryl compounds cysteine and cysteamine in the presence of ferrous ions. Similar reactions occur in the presence of copper ions but these are much slower. The initial interactions of the drugs and of oxygen with an iron-cysteine complex are extremely rapid: in the case of oxygen reaction half lives of 27 ms have been measured. Misonidazole also reacts rapidly with glutathione in the presence of ferrous ions and is subsequently reduced: metronidazole is reduced only slowly if at all. These reactions, which have been found to be inhibited by high concentrations of zinc ions, are discussed in the light of the known radiosensitizing and chemotherapeutic efficiencies of the nitro drugs and the side effect of peripheral neuropathy sometimes observed during their clinical use.

UR - http://www.scopus.com/inward/record.url?scp=0018144209&partnerID=8YFLogxK

M3 - Article

C2 - 277218

AN - SCOPUS:0018144209

VL - 37

SP - 16

EP - 19

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - SUPPL.3

ER -

Von denselben Autoren